Erin Butler, MS, CCC-SLP, Author at Dysphagia Cafe

1 POSTS 0 COMMENTS

Erin Butler, M.S., CCC-SLP is a speech-language pathologist who earned her master of science from Bowling Green State University in 2012. Erin has 10 years of clinical experience as a medical SLP primarily with the adult/geriatric population in the skilled nursing and long-term care settings. Erin's main areas of interest include assessment and treatment of both dysphagia and dementia. Erin is certified in Vital Stim, Adjunctive sEMG, Head and Neck PENS, Myofascial Release and MDTP and has previously been certified in Dementia Capable Care. She is the founder/manager of the NW OH Medical SLP Journal Club.

When Dementia and Dysphagia Co-Occur: The Role of the SLP

Erin Butler, MS, CCC-SLP - June 16, 2022

Scroll for Important Safety Information

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.